Each dose of Covishield and Covaxin likely to be capped at Rs 275 after getting regular market approval Read more
Stempeutics gets DCGI nod for phase-III clinical trial on its product for treating COVID patients Read more
DCGI seeks more data from SII over its application seeking emergency authorisation for Covovax Read more